| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |